Healthcare - Biotechnology - NASDAQ - US
$ 1.98
-4.81 %
$ 29.4 M
Market Cap
-0.22
P/E
Price Target
Average
405.05%
Revenue Forecast
Estimate
223.83%
EBIT
Estimate
--32.72%
Net Income
Estimate
20.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Longeveron Inc.
Wall Street analysts predict an average 1-year price target for LGVN of $10 , with forecasts ranging from a low of $10 to a high of $10 .
LGVN Lowest Price Target
Wall Street Target
10 USD
405.05%
LGVN Average Price Target
Wall Street Target
10 USD
405.05%
LGVN Highest Price Target
Wall Street Target
10 USD
405.05%
REVENUE FORECAST
Revenue Forecast Chart LGVN
EBIT FORECAST
EBIT Forecast Chart LGVN
NET INCOME FORECAST
Net Income Chart LGVN